The Claimed Intermediate Tcipatent — Process Patent Intelligence
Pharmaceutical Process Patent Intelligence Enhanced Structure Search

Process Patent Data for Marketed Drugs

A unique, curated database and intelligence platform covering process patents for marketed pharmaceutical drugs — offering text search, enhanced structure search, and targeted patent data not readily replicated from standard commercial databases.

TCIPATENT DATABASE — LIVE VIEW
Live rotation
INN / DrugRecords
4,303
Patent Specifications
25,865
Structures
4,303
Database Records
1,171
Records with Claimed Intermediates
1,379
Patentees

Process Patents: Hidden, Valuable, and Critical

As a marketed pharmaceutical drug approaches the end of its product patent term, a wave of process patents are filed — covering synthetic routes, key intermediates, and manufacturing improvements designed to secure commercial advantage when the drug goes generic.

These process patents are not listed by the FDA or EMA. They are buried within high-cost general patent databases alongside thousands of unrelated filings. Finding, interpreting, and tracking them is enormously time-consuming without specialist expertise.

The Claimed Intermediate database solves this problem directly: every record is identified, read, and abstracted by a pharmaceutical patent expert, then made fully searchable by drug name, intermediate structures, patentee, major jurisdictions, etc.

Text & Enhanced Structure Search

Search by drug INN, patentee name, or draw a chemical structure directly in the browser. Find exact matches, similarity, derivative, or substructure hits across thousands of records.

Expert Curation, Not Automation

Every patent record is individually reviewed and abstracted — not auto-scraped. The database surfaces drug synthetic routes often buried across hundreds of filings, presented in a clear visual format.

Commercial Synthesis Intelligence

Understand which pharmaceutical synthetic routes are the subject of a patent application, which intermediates are claimed, and what the competitive landscape looks like for commercial manufacturing profitability.

What Is a Claimed Intermediate?

A Claimed Intermediate is a novel pharmaceutical process intermediate that is claimed within a process patent specification — often carrying the same 20-year patent protection term if the patent is granted.

Identifying and tracking Claimed Intermediates is essential for Generic Manufacturers, Patent Attorneys and Commercial Chemists assessing freedom to operate, synthesis design, and route development.

The Tcipatent database is the only resource specifically designed to locate, catalogue, and make searchable these claimed intermediates across thousands of process patent specifications for marketed drugs.

Defining Properties of a Claimed Intermediate

✓
NoveltyA novel compound — not previously disclosed in the prior art — that forms part of a patented pharmaceutical synthetic route.
✓
High StabilityPreferably highly stable under normal conditions, enabling reliable handling and storage in a manufacturing context.
✓
Isolatability & PurifiabilityCapable of being isolated and purified to a high degree, with appropriate chirality where relevant.
✓
Compound Claim ProtectionClaimed as a compound in a process patent specification, conferring up to 20 years of patent protection if the patent is granted.

Access the Platform

The Tcipatent platform is available as a subscription database and as tailored bespoke reports. Both products draw on the same expertly curated dataset covering process patents published from January 2010 onwards.

Online Database Subscription

Full platform access with text & enhanced structure search

Subscription access to the complete Tcipatent database, updated on an ongoing basis as new process patents are published. Includes Monthly Reports as standard.

  • Covers EP, US, WO and additional jurisdictions as found
  • Full text search by drug INN, patentee, patent number etc.
  • Enhanced Chemical structure search — similarity, substructure, exact and derivative. Search by structure or SMILES
  • Visual presentation of drug synthetic routes and patent data
  • Basic patent status included in every record
  • Only new patent specifications — no repeated family equivalents
  • Subscription-based pricing — no additional per-hit costs
  • Historical drug patent data added on an ongoing basis
Enquire About Subscription

Reports

Monthly, quarterly, and bespoke patent intelligence reports

Structured patent intelligence reports drawn directly from the Tcipatent database, available as regular subscriptions or as fully customised bespoke reports to your specification.

  • Monthly Reports — the latest records added to the database in text-searchable PDF format
  • Quarterly Reports — a comprehensive quarterly digest of new process patents added to the platform
  • Bespoke Reports — customised by drug, patentee, jurisdiction, date range, or any other criteria you require
  • All reports delivered as text-searchable PDFs
  • Bespoke pricing on application — contact us to discuss your requirements
Request a Report

How the Database Is Built

Every record in the Tcipatent database is the result of expert human analysis — not automated scraping. This is what makes the platform uniquely valuable.

01 — IDENTIFY

New Process Patents Located

Newly published process patent specifications for marketed pharmaceutical drugs are identified across major jurisdictions as they are published.

02 — ANALYSE

Expert Patent Review

Each specification is read and analysed by an experienced pharmaceutical patent professional. Drug synthetic routes are identified and any claimed intermediates extracted.

03 — ABSTRACT

Structured Record Created

A structured database record is created including patent details, drug INN, patentee, claimed intermediates, structures, and basic patent status.

04 — DEDUPLICATE

Family Equivalents Excluded

Only new patent specifications are added — equivalent family members are excluded to avoid duplication. Equivalents remain accessible via standard patent databases.

05 — PUBLISH

Database Updated

New records are published to the live platform, with subscribers notified via Monthly Reports.

Eddie Kehoe — Principal, Tcipatent Ltd

Eddie Kehoe

Principal — Tcipatent Ltd

Eddie Kehoe has been searching, examining, abstracting, and interpreting patent specifications for over 50 years. Initially trained as a Chemist, he has covered most patent subject areas but has focused principally on pharmaceutical patents.

Patents represent a uniquely complex intersection of technological and legal matter, requiring a specific professional discipline to quickly and effectively understand their scope, claims, and commercial implications. Eddie brings this expertise to every record in the Tcipatent database.

Tcipatent was established to make this specialist knowledge accessible in a practical, scalable platform — enabling Pharmaceutical Companies, Patent Attorneys, Generic Manufacturers and Commercial Chemists to access curated process patent intelligence without the cost and time burden of in-house analysis.

LinkedIn Profile

Interested in the Platform?

Whether you are looking for subscription access to the database, a bespoke patent intelligence report, or would like to discuss acquiring or partnering with Tcipatent Ltd, we welcome your enquiry.

Contact Us Connect on LinkedIn